Full Description
"The Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease" brings you abstracts of the articles that reported the year's breakthrough developments in rheumatology, arthritis, and musculoskeletal disease, carefully selected from more than 500 journals worldwide. Expert commentaries evaluate the clinical importance of each article and discuss its application to your practice. There's no faster or easier way to stay informed! This year's edition gives readers the latest information on links between Cox-2 inhibitors and increased risk of cardiovacular disease, acetaminophen as initial therapy for osteoarthritis, difference between men and women with giant cell arteritis, use of cytokine levels to predict length of treatment for patients with giant cell arteritis, work-related musculoskeletal syndromes, and oral tolerance as possible therapy for autoimmune disease. "The Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease" publishes annually in February.
-
- 洋書電子書籍
- Re-reading the Mons…
